ESI–MS method for in vitro investigation of skin penetration by copper–amino acid complexes: from an emulsion through a model membrane

  • Lena Mazurowska
  • Kinga Nowak-Buciak
  • Mirosław Mojski
Original Paper
First Online:
Received:
Revised:
Accepted:

Abstract

Copper can be found in many cosmetic formulations, mainly as complexes with peptides, hydroxyacids or amino acids. The main reason that the usage of this element in this context is still increasing is its beneficial biochemical activity, although the mechanism that enables its complexes to permeate through skin barriers is largely unknown. The ability of copper complexes with amino acids to penetrate through the stratum corneum and participate in copper ion transport processes is key to their cosmetic and pharmaceutical activities. The penetration process was studied in vitro in a model system, a Franz diffusion cell with a liposome membrane, where a liquid crystalline system with physicochemical properties similar to those of the intercellular cement of stratum corneum was used to model the skin barrier. The influences of various ligands on the model membrane migration rate of copper ions was studied, and the results highlighted the crucial roles of metal ion complex structure and stability in this process.

Keywords

Copper Amino acids Diffusion cell Model membrane permeation ESI–MS 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

The Warsaw University of Technology financially supported the work. The authors are thankful to Lipoid GmBH (Germany) for the kind gift of Cerasome 9005, and they are grateful to Rafał Ruzik for valuable help with the ESI MS study.

References

  1. 1.
    Linder MC (2001) Mutat Res 475:141–152Google Scholar
  2. 2.
    Tapiero H, Townsend DM, Tew KD (2003) Biomed Pharmacother 57:386–398CrossRefGoogle Scholar
  3. 3.
    Brewer GJ (2003) Curr Opin Chem Biol 7:207–212CrossRefGoogle Scholar
  4. 4.
    Guy RH, Hostynek JJ, Hinz RS, Lorence CR (1999) Metals and the skin. Marcel Dekker, New YorkGoogle Scholar
  5. 5.
    Linder MC, Hazegh-Azam M (1996) Am J Clin Nutr Suppl 63:797–811Google Scholar
  6. 6.
    Ma Y, Ogino T, Kawabata T, Yoshino T, Yang BB, Okada S (1998) Free Rad Biol Med 25:568–575CrossRefGoogle Scholar
  7. 7.
    Sorenson JRJ (1985) Comp Ther 11:49–64Google Scholar
  8. 8.
    Solomon EI, Sundaram UM, Machonkin TE (1996) Chem Rev 96:2563–2605CrossRefGoogle Scholar
  9. 9.
    Ettinger MJ, Darwish HM, Schmitt RC (1986) Fed Proc 45:2800–2804Google Scholar
  10. 10.
    McArdle HJ, Gross SM, Danks DM (1988) J Cell Physiol 136:373–378CrossRefGoogle Scholar
  11. 11.
    Sarkar B (1997) Ann Neurol 41:134–136CrossRefGoogle Scholar
  12. 12.
    Deschamps P, Kulkarni PP, Gautam-Basak M, Sarkar B (2005) Coordin Chem Rev 249:895–909CrossRefGoogle Scholar
  13. 13.
    Meyer LA, Prohaska AP, Harris ZL (2001) J Biol Chem 276:36857–36861CrossRefGoogle Scholar
  14. 14.
    Van Dyke BR, Saltman P (1993) J Biol Chem 268:21533–21537Google Scholar
  15. 15.
    Mas A, Sarkar B (1992) Biochim Biophys Acta 1135:123–128CrossRefGoogle Scholar
  16. 16.
    Hostynek JJ (2003) Food Chem Toxicol 41:327–345CrossRefGoogle Scholar
  17. 17.
    Feldman RJ, Maibach HJ (1966) Arch Dermatol 91:649–651CrossRefGoogle Scholar
  18. 18.
    Hostynek JJ, Drecher F, Maibach HJ (2006) Food Chem Toxicol 44:1539–1543CrossRefGoogle Scholar
  19. 19.
    Walker WR, Reeves RR, Brosnan M, Coleman GD (1977) Bioinorg Chem 7:271–276CrossRefGoogle Scholar
  20. 20.
    Pirot F, Panisset F, Agache P, Humbert P (1996) Skin Pharmacol 9:43–52CrossRefGoogle Scholar
  21. 21.
    EC (2003) Seventh amendment of Directive 76/768/EEC on Cosmetic Products, Directive 2003/15/EC. European Communities, BrusselsGoogle Scholar
  22. 22.
    Balaguer A, Salvador A, Chisvert A, Melia M, Herraez M, Diez O (2006) Anal Bioanal Chem 385:1225–1232CrossRefGoogle Scholar
  23. 23.
    Mazurowska L, Mojski M (2007) Talanta 72:650–654CrossRefGoogle Scholar
  24. 24.
    Bosman IJ, Lawant AL, Aegaart SR, Ensing K, de Zeeuw RA (1996) J Pharm Biomed Anal 14:1015–1023CrossRefGoogle Scholar
  25. 25.
    Shokri J, Nokhodchi A, Dashbolaghi A (2001) Int J Pharm 228:99–107CrossRefGoogle Scholar
  26. 26.
    Oborska A, Arct J, Mojski M, Jaremko E (2004) J Appl Cosmet 22:35–42Google Scholar
  27. 27.
    Hatanaka T, Inuma M, Sugibayashi K, Morimoto Y (1990) Chem Pharm Bull 38:3452–3459Google Scholar
  28. 28.
    Matsuzaki K, Imaoka T, Asano M, Miyajima K (1993) Chem Pharm Bull 41:575–579Google Scholar
  29. 29.
    Houk J, Guy RH (1998) Chem Rev 88:455–471CrossRefGoogle Scholar
  30. 30.
    Haywood LJA, Sutcliffe P (1956) Analyst 81:651–655CrossRefGoogle Scholar
  31. 31.
    Schaefer H, Redelmeier TE (1996) Skin barrier. Principles of percutaneous Absorption. S. Karger AG, BaselGoogle Scholar
  32. 32.
    Połeć-Pawlak K, Ruzik R, Abramski K, Ciurzyńska M, Gawrońska H (2005) Anal Chim Acta 540:61–70CrossRefGoogle Scholar
  33. 33.
    Martell AE, Smith RM (1974) Critical Stability Constants. Plenum Press, New YorkGoogle Scholar
  34. 34.
    Wódzki R, Nowaczyk J (2001) J Appl Polym Sci 80:2705–2717CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Lena Mazurowska
    • 1
  • Kinga Nowak-Buciak
    • 1
  • Mirosław Mojski
    • 1
  1. 1.Warsaw University of Technology, Faculty of ChemistryWarsawPoland

Personalised recommendations